Immune Evasion of SARS-CoV-2 Omicron Subvariants

Since the SARS-CoV-2 Omicron variant (B.1.1.529) was declared a variant of concern (VOC) by the WHO on 24 November 2021, it has caused another global surge of cases. With extensive mutations in its spike glycoprotein, Omicron gained substantial capabilities to evade the antiviral immunity provided b...

Descripción completa

Detalles Bibliográficos
Autores principales: Ke, Hanzhong, Chang, Matthew R., Marasco, Wayne A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9501521/
https://www.ncbi.nlm.nih.gov/pubmed/36146623
http://dx.doi.org/10.3390/vaccines10091545

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9501521/
https://www.ncbi.nlm.nih.gov/pubmed/36146623
http://dx.doi.org/10.3390/vaccines10091545

Ejemplares similares